Trial now
JGB TECHS

(M1) Bullish Focus

AUSSIE 10-YEAR TECHS

(M1) New Multi-Month Highs

USDCAD TECHS

Clearing Major Support

AUDUSD TECHS

Sizeable Resistance Building

EURJPY TECHS

Needle Still Points North

EQUITIES

One US earnings release that could garner some interest today could be Johnson & Johnson - they're due pre-market. Outside of their EPS and revenue headlines, markets will be looking for any efficacy results of their COVID-19 vaccine, and whether testing is showing an efficacy of 80% or more.

  • Bloomberg today citing an Evercore ISI survey, in which their results show investors expect a "sustained rotation into reopening stocks" if the JNJ results show a decent level of effectiveness.
  • The last two quarters, JNJ have reported at 1140GMT/0640ET, so that seems a good guide for timing of any release we may see from them today.